BOUNDLESS BIO, INC. Earnings Per Share (Basic)
BOUNDLESS BIO, INC. (BOLD) reported Earnings Per Share (Basic) of -$1.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- BOUNDLESS BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.06.
- BOUNDLESS BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.60.
- BOUNDLESS BIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.58.
- BOUNDLESS BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.62.
- BOUNDLESS BIO, INC. earnings per share, basic for fiscal 2025 was -$2.60.
- BOUNDLESS BIO, INC. earnings per share, basic for fiscal 2024 was -$3.85.
- BOUNDLESS BIO, INC. earnings per share, basic for fiscal 2023 was -$40.65.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.06 10-Q · filed 2026-08-07 | -$1.66 10-Q · filed 2026-08-07 | -$2.24 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$2.86 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.60 10-Q · filed 2026-05-08 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$2.50 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$2.60 10-K · filed 2026-03-09 |
| 2025-09-30 | -$0.62 10-Q · filed 2025-11-05 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$2.03 10-Q · filed 2025-11-05 | -$2.76 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-06-30 | -$0.70 10-Q · filed 2026-08-07 | -$1.41 10-Q · filed 2026-08-07 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$2.89 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | -$0.71 10-Q · filed 2026-05-08 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$2.96 derived: net income ÷ weighted average shares · filed 2026-05-08 |
| 2024-12-31 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$2.25 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$3.85 10-K · filed 2026-03-09 |
| 2024-09-30 | -$0.74 10-Q · filed 2025-11-05 | -$1.51 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$3.22 10-Q · filed 2025-11-05 | -$5.22 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$0.77 10-Q · filed 2025-08-05 | -$2.78 10-Q · filed 2025-08-05 | -$5.45 derived: net income ÷ weighted average shares · filed 2025-08-05 | -$8.97 derived: net income ÷ weighted average shares · filed 2025-08-05 |
| 2024-03-31 | -$12.27 10-Q · filed 2025-05-09 | -$22.05 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$32.76 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$43.06 derived: net income ÷ weighted average shares · filed 2025-05-09 |
| 2023-12-31 | -$9.77 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$20.47 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$30.75 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$40.65 10-K · filed 2025-03-27 |
| 2023-09-30 | -$10.71 10-Q · filed 2024-11-07 | -$20.99 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$30.89 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$10.28 10-Q · filed 2024-08-12 | -$20.18 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$9.91 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |